fashion -WSS

fashion

author：hotspot 2025-09-27 17:03:03 - browse：55

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Biotech investment managers search for lucrative opportunities

WSS

Adam's Take: Intra

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Steward Health Care expansion into Malta flopped

Asbestos ban is immediate, but health effects will linger for decades

CRISPR technology availability, affordability needs to be expanded

'Patient friction coefficient' can gauge a clinical trial's patient burden

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Steward Health Care expansion into Malta flopped

Psychedelics group wrestles with new pharma identity

CRISPR technology availability, affordability needs to be expanded

After affirmative action ruling, medical educators look to 'holistic review'

Asbestos ban is immediate, but health effects will linger for decades

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Hepatitis C has a cure — but many Americans still lack access to it

Surgeons perform first xenotransplant using CRISPR'd pig kidney

hotspot

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Ukrainian soldiers say they owe lives to US

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Biotech investment managers search for lucrative opportunities

Pregnancy ages women, but effects reverse after delivery

This gene therapy has record $4.25 million price. It's saved children.

focus

Wikipedia

explore

hotspot